JAGUAR HEALTH, INC. Warrants and Rights Outstanding
JAGUAR HEALTH, INC. (JAGX) had Warrants and Rights Outstanding of $1.00 thousand as of 2022-03-31, per its 10-Q filed 2022-05-10.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:WarrantsAndRightsOutstanding · last filed 2023-03-24
- 2022-03-31: Warrants and Rights Outstanding $1.00K.
- 2021-12-31: Warrants and Rights Outstanding $1.00K.
- 2021-09-30: Warrants and Rights Outstanding $3.00K.
- 2021-06-30: Warrants and Rights Outstanding $7.00K.
| Period end | Warrants and Rights Outstanding | Warrants and Rights Outstanding as first filed |
|---|---|---|
| 2022-03-31 | $1.00K 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $1.00K 10-K · filed 2023-03-24 | |
| 2021-09-30 | $3.00K 10-Q · filed 2021-11-17 | |
| 2021-06-30 | $7.00K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $12.00K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $179.00K 10-K · filed 2022-03-11 | |
| 2020-09-30 | $126.00K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $4.09M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $2.00K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $3.00K 10-K · filed 2021-03-31 | $3.49K 10-K · filed 2020-04-03 |
| 2019-09-30 | $10.03K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $5.18M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $1.28M 10-Q · filed 2019-05-21 | |
| 2018-12-31 | $220.38K 10-K · filed 2020-04-03 | |
| 2018-09-30 | $48.24K 10-Q · filed 2018-11-19 | |
| 2018-06-30 | $74.47K 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $192.96K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $103.86K 10-K · filed 2019-04-10 | |
| 2017-09-30 | $163.08K 10-Q · filed 2017-11-20 | |
| 2017-06-30 | $551.88K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $1.25M 10-Q/A · filed 2017-06-23 | |
| 2016-12-31 | $799.20K 10-K · filed 2018-04-09 | |
| 2015-12-31 | $0.00 10-K · filed 2017-02-15 | |
| 2015-03-31 | $977.88K 10-Q · filed 2015-06-26 | |
| 2014-12-31 | $601.89K 10-K · filed 2016-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |